KnowTox: pipeline and case study for confident prediction of potential toxic effects of compounds in early phases of development by Morger, Andrea et al.
Morger et al. J Cheminform           (2020) 12:24  
https://doi.org/10.1186/s13321-020-00422-x
RESEARCH ARTICLE
KnowTox: pipeline and case study 
for confident prediction of potential toxic 
effects of compounds in early phases 
of development
Andrea Morger1 , Miriam Mathea2 , Janosch H. Achenbach2 , Antje Wolf2 , Roland Buesen2 , 
Klaus‑Juergen Schleifer2 , Robert Landsiedel2  and Andrea Volkamer1* 
Abstract 
Risk assessment of newly synthesised chemicals is a prerequisite for regulatory approval. In this context, in silico meth‑
ods have great potential to reduce time, cost, and ultimately animal testing as they make use of the ever‑growing 
amount of available toxicity data. Here, KnowTox is presented, a novel pipeline that combines three different in silico 
toxicology approaches to allow for confident prediction of potentially toxic effects of query compounds, i.e. machine 
learning models for 88 endpoints, alerts for 919 toxic substructures, and computational support for read‑across. It 
is mainly based on the ToxCast dataset, containing after preprocessing a sparse matrix of 7912 compounds tested 
against 985 endpoints. When applying machine learning models, applicability and reliability of predictions for new 
chemicals are of utmost importance. Therefore, first, the conformal prediction technique was deployed, compris‑
ing an additional calibration step and per definition creating internally valid predictors at a given significance level. 
Second, to further improve validity and information efficiency, two adaptations are suggested, exemplified at the 
androgen receptor antagonism endpoint. An absolute increase in validity of 23% on the in‑house dataset of 534 
compounds could be achieved by introducing KNNRegressor normalisation. This increase in validity comes at the cost 
of efficiency, which could again be improved by 20% for the initial ToxCast model by balancing the dataset during 
model training. Finally, the value of the developed pipeline for risk assessment is discussed using two in‑house triazole 
molecules. Compared to a single toxicity prediction method, complementing the outputs of different approaches 
can have a higher impact on guiding toxicity testing and de‑selecting most likely harmful development‑candidate 
compounds early in the development process.
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Introduction
Before newly developed chemicals can be approved, their 
potential toxic effects on humans and the environment 
inevitably need to be assessed. Most regulations such as 
REACH [1] require animal studies for risk assessment. 
E.g. more than 540,000 animals were employed in Ger-
many in 2017 for production, quality control, and safety 
assessment [2].
Given the ever growing amount of available toxic-
ity data, computational toxicity prediction methods 
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animal testing. Using historical data, they can help to dis-
close relationships between compounds that would not 
have been identified manually and, thus, reveal potential 
risk of compounds in early phases of development. In 
silico predictions can hint at potentially hazardous inter-
actions or critical structural moieties of new molecules. 
If the corresponding assays are conducted first, harm-
ful compounds can be filtered out before performing a 
wide range of additional experiments. Moreover, in silico 
methods can support product optimisation and reduce 
long-term animal toxicity studies [3, 4].
In silico strategies for supporting risk assessment range 
from computational read-across approaches and search 
for substructural alerts to statistical methods. Espe-
cially, quantitative structure-activity relationship (QSAR) 
techniques such as machine learning (ML) [5] methods 
require a large precompiled dataset.
The US Environmental Protection Agency (EPA) has 
provided the ToxCast dataset [6] consisting of roughly 
8000 compounds, such as pharmaceuticals, pesticides, 
and environmental chemicals, that were tested on up 
to 1000 endpoints, e.g. cell cycle, steroid receptors, and 
cytotoxicity. ToxCast has since been used: to develop 
QSAR models [7–9]; to generate biological fingerprints 
for in vivo endpoint predictions [10]; to decipher adverse 
outcome pathways [7, 11]; and as a basis for read-across 
[12–14].
Read-across is a common, often manual, approach 
in toxicology [12, 15, 16], based on the assumption that 
similar molecules can evoke similar toxic effects. Miss-
ing information on query chemicals’ properties may 
be gathered by reading across information from very 
similar molecules. Using different molecular encodings 
and diverse similarity measures, computers can search 
through large compound databases to identify the most 
similar compounds and—given a decent similarity—
transfer knowledge to a query compound. Prerequisite 
for successful read-across is a robust and reproducible 
test system of the underlying experimental data [16], 
i.e. a standardised assay set-up to ensure comparable 
read-outs. Another challenge is the determination of the 
amount of required similarity between two compounds 
that allows safe and reliable knowledge transfer.
Since often not the complete molecule, but rather a 
specific functional group or fragment, is responsible for 
an unwanted effect, identifying such toxic substructures 
in a query molecule is of high practical value. Several 
authors published lists of toxic alerts or other undesired 
substructures which can be used to flag novel com-
pounds [17, 18]. For instance, the OCHEM ToxAlert 
server allows to browse and query structural alerts for 
various toxicological endpoints [17, 19].
Often the relationship between molecular structure 
and toxic effect is not linear, thus, statistical methods 
such as QSAR models are applied to recognise more 
complex patterns in datasets. The set-up of high-per-
forming toxicity prediction models has recently been 
promoted in the Tox21 Data Challenge. Research groups 
competed in model performance on 12 nuclear receptor 
and stress response pathways trained on roughly 10,000 
compounds [20], including various ML algorithms such 
as random forest, support vector machine, and deep 
learning approaches [21–23]. The winning models on 
all 12 endpoints showed AUC-ROC scores between 0.81 
and 0.95 on an external blinded test set [20].
Fuart Gatnik and Worth published an overview on 
publicly and commercially available software tools, such 
as the well-known TOPKAT [24] and DEREK [25] meth-
ods, for toxicity prediction [26]. Concluding, the authors 
stated that the availability and quality of the models is 
endpoint-dependent and they emphasised on the obser-
vation that generally more research is needed in terms 
of assessment of the applicability of the in silico mod-
els. Besides pure predictions, for practical applications, 
knowledge about the applicability domain, i.e. the space 
of chemicals the model can make reliable predictions for, 
is of major importance. Hanser et  al. [27] suggested to 
further divide this concept into three domains: applicabil-
ity, reliability, and decidability. The applicability domain 
indicates whether a model can be applied to make a pre-
diction for a certain use case. It can be defined, for exam-
ple, by a convex hull around the main components of a 
principal component analysis (PCA) fitted on the fea-
tures of the training data. The reliability domain gives 
information on whether the obtained prediction is reli-
able enough for the use case. It can be explored by inves-
tigating the average  distance to the nearest neighbours. 
The decidability domain returns if a clear decision can be 
made, based on the outcome of the prediction. Therefore, 
the distribution of the nearest neighbour’s labels can be 
analysed [27].
A recently promoted method for confidence estima-
tion, especially regarding reliability and decidability, is 
conformal prediction (CP) [28, 29]. A conformal predic-
tor returns, whether enough evidence is given to reliably 
assign the query substance to a certain class. CP models 
have recently been developed and applied in drug discov-
ery [29–31], and toxicology, e.g. to predict cytoxicity [32], 
endocrine disruption [33], and skin penetration [34]. 
Moreover, recently, eMolTox was introduced, a web-
server offering 174 CP models [35]. However, to the best 
of our knowledge, few information about applying such 
models to real-world use cases has been published.
In this work, KnowTox, a holistic toxicity prediction 
approach, that integrates refined conformal predictors, 
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structural alerts, and read-across support based on 
molecular similarity, is introduced and applied to indus-
trial chemicals. The main source of toxicity information 
is the publicly available ToxCast dataset. Being aware of 
the challenge to apply ML models trained on public data 
to an industrial setting, first, the CP model performance 
was optimised focusing on the androgen receptor end-
point and validated on an in-house dataset. The focus 
is on endocrine disruption as a disturbance of steroidal 
hormone homeostasis can cause severe toxic effects, e.g. 
leading to male feminisation or reproduction disorders 
[36, 37]. Thus, screening for agonistic and antagonis-
tic activities on androgen and estrogen receptors is fre-
quently conducted in yeast cells (so-called YES- and YAS 
assays [38]) and sufficient validation data is available. 
Finally, CP models were trained using the same CP set-up 
for another 87 ToxCast endpoints with enough training 
data available. Moreover, with KnowTox, the refinement 
of chemical structures is guided by the implementa-
tion of warnings about unfavourable structural moieties 
described in literature [35, 39, 40]. To support read-
across, a similarity search is proposed which can auto-
matically point to toxic effects in cells and interactions 
known for the most similar molecules within ToxCast. 
In a case study, the potential of KnowTox is exemplified 
on two in-house triazoles. Multiple components of the 
KnowTox pipeline indicated liver toxicity and endocrine 
disruption which is in accordance with literature and ret-
rospective test results.
Data and methods
In the following, first the main datasets and their prepara-
tion will be introduced, followed by the individual meth-
ods for the KnowTox toxicity prediction tool, including 
CP, PCA, toxic substructure and similarity search.
Datasets
ToxCast dataset
The source of molecules and assay data for KnowTox is 
the freely available ToxCast dataset provided by the EPA. 
It consists of over 8000 compounds tested on up to 1092 
different toxic endpoints. The data was downloaded from 
EPA’s National Center for Computational Toxicology  [41] 
(date 23.06.2017). Toxicity values were directly adopted 
from the hitcalls defined by the EPA. Flags were not con-
sidered, but endpoints corresponding to background meas-
urements were excluded. This yielded a sparse matrix of 
8390 compounds with respective toxicity value (0,1, NaN) 
per tested endpoint (985 total). The ToxCast dataset repre-
sented the basis for the similarity search as well as for CP.
Androgen receptor datasets
To validate and optimise the CP set-up for model applica-
tion on external data, three datasets for androgen recep-
tor antagonism (AA) were collected (see Table 1).
ToxCast‑AA The AA assay from ToxCast (assay end-
point id 762) was selected. The assay originates from the 
Tox21 platform and was conducted in human kidney cells 
(HEK293T). It is a reporter gene assay that measures beta 
lactamase induction upon antagonistic activity regulated 
by the human androgen receptor. Activity data are avail-
able for 6710 chemicals.
In‑house‑AA The in-house dataset from BASF consists 
of 534 chemicals tested in YES/YAS assays [38]. They are 
mainly pesticides, such as fungicides and herbicides, and 
not part of the ToxCast dataset. These compounds were 
not launched on the market but failed for different rea-
sons during the development. In the YAS assay, human 
androgen receptor is expressed in yeast cells. Upon bind-
ing of an androgenic compound, the lacZ reporter gene is 
activated, which is responsible for expression of β-galac-
tosidase. Presence of this enzyme can be detected by a 
colour change. Anti-androgenic effects can be observed 
if binding of a known androgenic agent is inhibited and 
thus the colour change is reduced or does not occur at all. 
YES assays are conducted similarly, but in yeast cells that 
express the human estrogen receptor.
External‑AA Another external dataset, collected by 
Jensen et al. [42] and by Vinggaard et al. [43] for QSAR 
modelling, was downloaded from Norinder et  al. [33]. 
The dataset consists of initially 925 molecules that were 
especially selected to represent a large chemical space 
[43]. 361 of these molecules, that are not part of Tox-
Cast, were used in this study. Data originate from an AA 
assay reporting luminescence response upon inhibition of 
androgen binding to a synthetic androgen receptor and 
following gene expression in chinese hamster ovary cells.
Table 1 Size and  purpose of  androgen receptor 
antagonism datasets used to  validate the  original 
conformal prediction model
Dataset Purpose Actives Inactives
ToxCast‑AA 762 Train and test model 868 5842
In‑house‑AA Validation I 280 254
External‑AA Validation II 160 201
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Dataset preprocessing
Standardisation
Each molecule was standardised by applying the follow-
ing workflow: first, duplicates (compounds tested more 
than once for a specific endpoint) were removed. Only 
one instance was kept if the assay outcomes agreed—
otherwise both instances were discarded. Next, mol-
ecules were standardised using the IMI eTox project 
standardiser tool [44]. This included discarding non-
organic compounds, application of certain structure 
standardisation rules (e.g. handling of tautomers, shift-
ing protons between heteroatoms), neutralisation, and 
removal of, mainly organic, salts. Due to this standardi-
sation step new duplicates occurred; they were treated 
as described above. Next, remaining mixtures as well 
as fragments with less than three heavy atoms were 
removed yielding a cleaned dataset of 7912 ToxCast mol-
ecules tested on up to 985 endpoints (see Fig. 1, top). The 
resulting total number of active and inactive compounds 
for the AA datasets are listed in Table 1.
Descriptor calculation
For similarity search as well as CP, all molecules were 
encoded by molecular descriptors implemented in 
RDKit. For similarity search and the original CP model, 
a combination of the SMARTS-pattern based MACCS 
keys and the circular-environment based Morgan fin-
gerprint (radius 3, 1024 bits) was chosen. MACCS keys 
[45] represent the presence or absence of predefined 
functional groups. Morgan fingerprints [46] are a more 
abstract representation of a molecule, covering every 
atom and its circular environment including all atoms 
and bonds within a defined radius. Concatenation of the 
two descriptors resulted in a 1191-bit long feature vec-
tor representation per molecule. For the normalised and 
normalised + balanced CP models (see Table  2), the 
concatenated descriptor (binary values) was reduced to 
bits with feature variance of equal or higher than 0.01. 
Additionally, 200 physicochemical descriptors within 
RDKit [47] (float values) were calculated, normalised 
and reduced (feature variance threshold 0.001). Finally, 
these two descriptor sets were concatenated resulting in 
a feature vector of length 1341. Normalisation of phys-
icochemical parameters and feature reduction were per-
formed based on all standardised ToxCast molecules.
KnowTox pipeline
KnowTox allows input of a query molecule and offers 
in silico support for risk assessment from various view 
points, comprising CP, similarity search to support read-
across, and search for toxic substructures (see Fig. 1). In 
the following, the individual methods will be explained.
Fig. 1 Overview of KnowTox. Combining toxicity information from 
different sources, the complementary outputs of the KnowTox tool 
help to generate a holistic toxicity prediction picture for a novel 
query compound. ToxCast Database bar plot: Number of actives 
(grey) and inactives (blue) available per endpoint, sorted by number 
of actives. Red vertical line: CP models were built for the endpoints 
on the left side of the threshold line (at least 300 active and inactive 
compounds tested, red horizontal line)
Table 2 Conformal prediction models built for androgen receptor antagonism
a nc: nonconformity score
b physicochemical descriptors
Model name Descriptors nca Balancing
Original Morgan + MACCS Default No
Normalised Morgan + MACCS +  physchemb Normalised No
Normalised + balanced Morgan + MACCS +  physchemb Normalised Yes
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Machine learning and conformal prediction
General CP workflow The CP framework is built on top 
of ML models and is designed to make valid predictions at 
a given significance level (SL), assuming exchangeability 
[30]. An overview of the CP workflow used here (offline-
mode, binary classification setting) is shown in Fig.  2. 
Similar to the standard ML setting, the dataset is stratified 
and randomly split into a training and a test set. Then, an 
additional calibration step is introduced, in which training 
data is further split into a proper training and a calibra-
tion set. An underlying ML model, e.g. a random forest, is 
fitted on the proper training set and used to make a pre-
diction (probability pˆ ) for compounds of the calibration 
and the test set. The prediction outcome per class is trans-
formed into a so-called nonconformity score  (nc score). 
A nonconformity error function is chosen in the way that 
more ideal predictions yield lower nc scores; a typical 
error function for random forest classification models is 
the inverse probability (Eq. 1):
To improve reliability estimation of predictions, an addi-
tional normaliser regression model (e.g. kNN) can be fit-
ted on the descriptors of the proper training set and their 
nc scores. For a new compound, the normaliser regres-
sion model returns a normalised nc score ( nc scorenorm ), 
(1)nc score = 1− pˆ
by dividing the nc score of the compound by the average 
nc score of the compound’s k nearest neighbours within 
the proper training set (see Eq. 2).
Using mondrian classification [48], the CP algorithm 
generates for each class a sorted list of nc scores or 
nc scoresnorm for the calibration set. The ratio of these 
nonconformity scores higher, and thus more noncon-
forming, than the nc score predicted for a query com-
pound is called p-value. If a p-value is larger than a given 
SL ǫ (maximum allowed error rate), that label is assinged 
to a compound. Thus, for a binary classification problem, 
the output prediction set per compound contains either 
one class ({0},{1}), both classes ({0,1}), or an empty pre-
diction set ({}). To obtain more stable predictions, multi-
ple conformal predictors can be trained and the p-values 
are averaged, so-called aggregated conformal predictors 
(ACPs) [49] are generated.
CPs are typically evaluated regarding validity, efficiency 
and accuracy. Validity is defined as the ratio of predic-
tions containing the correct label. A common efficiency 
measure is the ratio of single class predictions (SCPs). 
Accuracy of SCPs corresponds to the ratio of correct 




Fig. 2 Schematic description of CP workflow. Data is split into training and test set (blue box). The training set is further divided into calibration 
(red box) and proper training set (violet box). An ML model is fitted on the proper training set and used to predict compounds of the calibration 
and test set. Predictions are transformed into nonconformity scores (nc scores). Calibration is conducted by sorting the nc scores of the calibration 
set (class‑wise, mondrian) into two lists. The nc score of a test compound is arranged in the list and thus the p‑value calculated. An additional 
normaliser model (green box) can optionally be fitted on the descriptors and nc scores of the compounds of the proper training set
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CP model set‑up in this study Three different settings for 
CP were applied. The corresponding models will further 
be called ’original’, ’normalised’ and ’normalised + bal-
anced’ model (see Table 2).
For the original model, data was split into 80% train-
ing and 20% test data. Within each loop of a fivefold 
cross-validation, an ACP with 25 loops was generated. In 
each ACP loop, training data was split into 70% proper 
training and 30% calibration data (see Carlsson et  al. 
[49]). Random forest models (500 estimators, else default 
parameters) were trained on the proper training sets and 
the predictions calibrated using the respective calibration 
sets (inverse probability error function, mondrian condi-
tion). P-values were aggregated by their median as sug-
gested by Linusson et al. [50]. Finally, the mean p-value of 
the cross-validation was calculated.
For the normalised model, information from the near-
est neighbours in the training set was taken into account 
as described in Eq.  2. The normaliser model was fitted 
using the KNNRegressor algorithm (scikit-learn, default 
parameters).
In the normalised + balanced model, per ACP loop, 
the proper training and calibration data were five times 
randomly subsampled to equal numbers of actives and 
inactives.
After evaluation, normalised + balanced models were 
built for all ToxCast endpoints for which at least  600 
compounds were measured—300  active (toxic) and  300 
inactive (non-toxic)—yielding 88 CP models (see Fig.  1, 
ToxCast Database bar plot, vertical red threshold line).
Principal component analysis (PCA) for AA data
For chemical space analysis, a 2-component PCA was 
fitted on ToxCast AA data. ToxCast-AA, in-house-AA, 
and external-AA data were projected into the descriptor 
space. Same descriptors were used as described for the 
normalised and normalised + balanced CP models.
Structural alerts
To identify potentially toxic or unwanted substructures in 
the query molecules, known structural alerts, encoded as 
SMARTS patterns, collected from literature are used. A 
list of 919 structural alerts incorporated in KnowTox was 
kindly provided by the authors of eMolTox [35]. Using 
RDKit, a substructure search for all these patterns in the 
query molecule is performed. Matching substructures 
are stored together with information about the associated 
toxic effect, individually highlighted in the molecule and 
labelled.
Similarity search and read‑across
Computational support for read-across in KnowTox 
is implemented via a similarity search and subsequent 
extraction of information from ToxCast. For similarity 
search, a query compound is compared to all ToxCast 
compounds using the calculated descriptors. Finally, 
ToxCast compounds are ranked by Tanimoto similar-
ity to the query compound. The tool returns the most 
similar compounds together with their  respective maxi-
mum common substructure (MCS) with the query com-
pound highlighted. Subsequent read-across is supported 
by extracting experimental activity of these similar mol-
ecules from the ToxCast dataset for all 985 endpoints.
Python libraries and versions
Molecules were standardised using the standardiser 
library [44] version 0.1.9. Descriptor calculation, struc-
tural alerts and similarity search were implemented using 
RDKit [47] version 2018.03.4. For local calculation of fea-
ture variances, normalisation of physicochemical param-
eters, and PCA, scikit-learn [51] version 0.19.2 was used. 
CP models were trained using nonconformist [52] ver-
sion 2.1.0 and underlying ML models using scikit-learn 
(version 0.19.0). Plots were generated using matplotlib 
version 2.2.3.
Supplementary information on github
A github repository with supplementary information is 
provided under https ://githu b.com/volka merla b/knowt 
ox_manus cript _SI. It contains the pre-processed ToxCast 
and external-AA data, as well as a notebook demonstrat-
ing the conformal prediction set-ups used in this work.
Results and discussion
In this section, first, the optimisation of the CP model 
with respect to applicability to in-house and external data 
will be discussed, with focus on prediction of AA assay 
outcome as well as on the complete set of 88 ToxCast 
endpoints. Finally, the full spectrum of predictions pro-
vided by KnowTox will be show cased on two triazoles.
Conformal predictors—validation of AA model
The aim of this study was to generate reliable toxicity 
prediction CP models which can be applied to in-house 
industrial chemicals. Data from the freely available and 
comparably large ToxCast toxicity database  is used, 
which contains experimental data from consistent meas-
urements per assay endpoint. As there is a shift in chemi-
cal and descriptor space expected, when applying the 
models to in-house compounds, it is important to vali-
date the method carefully. Thus, a CP model to predict 
androgen receptor antagonism (AA) was selected for 
validation. Here, an in-house dataset with 534 indus-
trial compounds was available, as well as another exter-
nal dataset with 361 compounds. AA is an important 
endpoint to examine a compounds’ risk for endocrine 
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disruption disorders such as male feminisation or sexual 
disruption in fish [36] and other species [37].
By design, conformal predictors are valid at a given SL, 
assuming data exchangeability [30]. This is also observed 
when training a standard CP model on ToxCast AA data. 
Figure 3a shows a calibration plot of the internal valida-
tion of the original ToxCast-AA model. Ideally, the error 
rate is equal to the significance (diagonal in Fig. 3a), thus, 
the original ToxCast-AA model is valid (orange line in 
Fig.  3a). Also, high efficiency (ratio of SCPs) of 0.87 is 
achieved at SL 0.2. Since evaluation at SL 0.2 is com-
monly used in literature, the values will also be given 
when describing the further validation process. Further-
more, the performance of the ToxCast-AA model is in 
Fig. 3 Calibration plots of the original, normalised, and normalised + balanced ToxCast‑AA models applied to internal validation, in‑house‑AA and 
external‑AA data
Table 3 Comparison of  original conformal prediction model for  androgen receptor antagonism  at 0.2 SL with  other 
studies from literature
a Values of models fitted on two different AA datasets.
b Three models with different fingerprints trained on one AA dataset
c class 1 = actives, class 0 = inactives
Model Validity Efficiency Accuracy
All Class  1c Class  0c All Class  1c Class  0c
KnowTox‑AA 0.81 0.82 0.81 0.87 0.80 0.78
eMolTox [35]a – 0.76–0.81 0.81–0.82 0.94–0.99 – –
Norinder et al. [33]b 0.80–0.81 0.81–0.83 0.79–0.82 – 0.79–0.82 0.78–0.79
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line with two other AA models extracted from literature 
(see Table 3), i.e. the eMolTox webserver [35] and work 
by Norinder et al. [33]. Validity, efficiency, and accuracy 
values for all three studies  (if reported) at SL 0.2 are in 
the range of 0.76–0.83, 0.87–0.99, and 0.79–0.82, respec-
tively. Although the above described AA models all use 
CP, they are only partly directly comparable as underly-
ing data, techniques and/or features differ (see Table 4). 
Note that some other QSAR models for AA have been 
published, based on similar data, using random for-
est, deep learning [53], and the Case Ultra system [54]. 
Since set-up and reported performance measures differ 
from this CP study, they can not directly be compared. 
Very recently, CoMPARA, an extensive study on andro-
gen receptor modelling, was published by Mansouri et al. 
[55]. Scientists from 25 research groups have contributed 
to consensus models for androgen receptor binding, ago-
nism, and antagonism with a predictive accuracy of 78% 
for the AA evaluation set (which is in the same range as 
the CP accuracy (SCP) obtained for the original Know-
Tox-AA model, see Table 3). The individual AA models 
were trained on 1525 ToxCast chemicals using, amongst 
others, neural networks as well as tree-based and linear 
modelling approaches.
When applying the original ToxCast-AA model to the 
libraries of in-house (Fig.  3b) and external molecules 
(Fig.  3c), validity at 0.2 SL dropped from 0.81 for the 
internal validation to 0.59 for the in-house dataset. Fur-
thermore, a high discrepancy was observed between the 
ratio of correct predictions of the active (0.98) and inac-
tive (0.16) class for the in-house data (see Additional 
file  1: Table  S1). Reasons for lower validity could be 
lacking exchangeability between the compounds of the 
datasets (pharmaceuticals vs. industrial chemicals) and 
data originating from different assays.
Hence, the chemical space was analysed with respect 
to 1) the most similar compounds and 2) the descriptor 
space using  PCA. First, the average Tanimoto similarity 
to the ten most similar molecules in ToxCast decreases 
from 0.51 for intra ToxCast similarity to 0.44 for external 
data and 0.37 for in-house data. Second, the PCA (Fig. 4) 
reveals that the in-house data (blue dots) shows the high-
est density in the lower right corner, which is different 
from the dense area of the ToxCast data (red dots). The 
external dataset (grey dots) is more similar to the Tox-
Cast distribution, occupying a dense area in the middle 
of the plot. Varying distribution and density contribute to 
poor exchangeability between the different datasets.
To improve reliability of the models, the chemical space 
was considered by including information about the near-
est neighbours to normalise the conformal predictions. 
While such a normalisation of the nc scores is important 
for regression models [56, 57], to the best of our knowl-
edge, it has not been applied to classification tasks so 
far. Including the KNN normalisation clearly improved 
validity for internal validation and the in-house dataset 
from 0.81 to 0.85 and from 0.59 to 0.82 at 0.2 SL, respec-
tively (see Additional file  1: Table  S2). Figure  3d,e show 
the lower error rate at a higher confidence area (small 
SLs), but decreased efficiency. Improved validity comes 
with the cost that less SCPs are made by the model, i.e. 
efficiency of 0.37 for ToxCast-AA and 0.21 for in-house-
AA at 0.2 SL. From an application point of view, this is 
acceptable, since it is preferred to make no prediction 
rather than a wrong assertion.
Table 4 Information on  KnowTox-AA and  other CP 
methods using the random forest ML algorithm to predict 
androgen receptor antagonism
a ACP aggregated conformal predictor, CCP cross-conformal predictor [48]
b Two models ((1), (2)) fitted on two different AA datasets
c Three models ((1), (2), (3)) with different fingerprints trained on one AA dataset
d Data for a total of 174 CP models originated from ChEMBL, Pubchem, Toxnet, 
eChemPortal databases and literature [35]











ACP Morgan + physchem
Norinder et al. 
[33]c





Fig. 4 ToxCast, in‑house and external data are projected into the 
descriptor space of a 2‑component PCA trained on ToxCast‑AA data
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Nevertheless, still, a high discrepancy between the 
accuracy of the active and inactive classes can be 
observed, with the highest discrepancy of 0.54 for the 
prediction of the external-AA data (see Additional file 1: 
Table S2). This is due to the high imbalance in the train-
ing data with a ratio of 1 active to 6.7 inactives in which 
the KNN algorithm is searching for nearest neighbours. 
While balancing in a mondrian ACP setting is normally 
not necessary, in the case of the additional KNN normali-
sation, random equal size sampling of the proper training 
and the calibration set, clearly reduced the discrepancy 
between the two classes for accuracy, as well as efficiency 
(see Table 5, Fig. 3g–i).
The following factors should be noted regarding model 
performance: Firstly, the refined, normalised + balanced 
conformal predictors have been validated for use at low 
SLs. They are valid on the in-house dataset at SLs below 
0.3, on the external dataset below 0.2. Therefore, predic-
tions for the case study compounds are based on SL 0.2. 
As there is no interest in predictions with high error rates, 
the low validity at higher SLs can be ignored. Secondly, 
the three datasets all originate from different assays (i.e. 
performed in human, yeast, and hamster cells; a human 
androgen receptor was expressed in both human and 
yeast cells). Due to a limited amount of available toxicity 
data, it is inevitable to compare data from different organ-
isms, nevertheless, caution should be exercised.
The knowledge gained from creating the normalised + 
balanced model was applied to the remaining endpoints of 
the ToxCast dataset. Using the validated strategy, totally, 
88 models were built with overall validity between 0.81 
and 0.86, and overall efficiency between 0.32 and 0.68 at SL 
0.2 (see Fig. 5, top). The accuracy of single class predictions 
ranged from 0.65 to 0.95 (see Fig. 5, bottom). Numbers for 
all 88 models and information about the endpoints can be 
found in Additional file 1: Tables S4 and S5, respectively.
KnowTox—case study
If KnowTox is queried with a compound of interest, 
three modules are envoked: conformal prediction  (CP) 
for 88 endpoints, screening for unfavourable structural 
moieties, and support for read-across from similar com-
pounds (see Fig. 6).
In this section, KnowTox usage is exemplified on two 
triazoles from the in-house dataset. They were designed 
as potential fungicides, but discontinued for various rea-
sons. Both molecules share an epoxide structure with 
two halogenated phenyl moieties and a triazole ring with 
a thioether substitute (see Fig. 6a).
Table 5 Evaluation of normalised +  balanceda conformal prediction model for androgen receptor antagonism at 0.2 SL
a normalised nc score and balancing of calibration and proper training set
b cl.: class (class 1 = actives, class 0 = inactives)
Dataset Purpose Validity Efficiency Accuracy
All cl.1b cl.0b All cl.1b cl.0b All cl.1b cl.0b
ToxCast‑AA train model 0.85 0.84 0.85 0.57 0.39 0.60 0.89 0.76 0.91
In‑house‑AA validation I 0.90 0.90 0.89 0.20 0.18 0.23 0.75 0.80 0.71
External‑AA validation II 0.80 0.76 0.82 0.43 0.33 0.52 0.74 0.67 0.78
Fig. 5 Evaluation of final 88 CP models. Top: validity vs. efficiency for 
inactives (blue) and actives (grey). Bottom: sorted, overall accuracy
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Fig. 6 KnowTox tool applied in a case study. a Triazoles1&2 used as query compounds for the case study. b Output of CP. Grey: number of 
endpoints per family available for CP. Red and blue: number of endpoints where triazoles1&2 were predicted to be active (SCP) at SL 0.2. c Three 
selected toxic alerts found for triazoles1&2. (Note that the potentially critical “triazole” substructure is not considered in this work). d Triazole1 
(left) and triazole2 (right) and their most similar molecules in ToxCast including CAS number and Tanimoto similarity. Red: maximum common 
substructure. e Experimental information from ToxCast for propiconazole (left) and bromuconazole (right). Grey: available assays in ToxCast. Blue: 
assays where compound was tested active
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Firstly, a conformal prediction with every of the above 
described 88 models is made. Each model returns two 
p-values, one for the inactive (p0) and one for the active 
(p1) class. The higher p-value denotes the class the 
compound is most likely assigned to. For example, the 
ToxCast-AA model predicts triazole1 to be active with 
p-values p0 = 0.19 and p1 = 0.56 . In literature, CPs 
are often evaluated at a specified maximum accepted 
error rate (equivalent to SL ǫ ). For instance, if no more 
than 20% errors are accepted ( SL = 0.2 ), the result is a 
prediction set containing all labels with p-values above 
0.2. Thus, triazole1 is predicted AA ({1}) while triazole2 
( p0 = 0.21 , p1 = 0.60 for AA prediction) is assigned both 
labels ({0,1}). Therefore, no decision is made for triazole2. 
However, if 25% errors would be allowed ( SL = 0.25 ), tri‑
azole2 would also be predicted to be AA only ({1}).
Alternatively, evaluation can be independent from 
a predefined SL, i.e. with respect to credibility and 
confidence [28]. Credibility is defined as the largest 
p-value, this means the highest SL where a compound 
is still assigned to the corresponding label. Confidence 
is defined as 1–second largest p-value; since a high 
p-value of an alternate class reduces the confidence in 
the prediction. Triazole1 is predicted to be AA with 
credibility = 0.56 and confidence = 0.81.
Referring to the three domains concept by Hanser et al. 
[27] (applicability, reliability, decidability), mentioned in 
the introduction, higher p-values, indicate higher relia-
bility of a prediction while a large difference between the 
two p-values corresponds to increased decidability.
Considering the predictions by all 88 CP models (see 
Fig.  6b), both triazoles were predicted to be only active 
(SL 0.2) at a total of 15 endpoints, related to DNA bind-
ing, nuclear receptors, cell cycle as well as for aromatase 
inhibition (CYP19A1). A full list of the p-values for the 
predictions can be found in Additional file 1: Table S3.
Potential interaction of triazoles with aromatase can 
be explained through the mode of action of triazole fun-
gicides. They inhibit the biosynthesis of ergosterol—an 
essential component of fungal cell membranes—chang-
ing the composition of the cell membrane. More pre-
cisely, the fungal enzyme lanosterol 14α-demethylase 
(CYP51) is inhibited which is closely related to human 
CYP15 and CYP19 (aromatase). Homology of fungal 
CYP51 to human CYP19 suggests likewise effects on 
steroidogenesis in humans [58]. Aromatase is responsi-
ble for catalysing the transformation of androgens into 
estrogens [59]. Inhibition can have a severe impact on 
hormone levels, though the actual physiological effects 
remain unclear [60, 61].
Besides, both triazoles were predicted to induce tran-
scription factor activity and, thus, elevate the level of 
pregnane X receptor (PXR) response element and phe-
nobarbital-responsive enhancer module mRNA. The two 
response elements are bound by members of the endo-
geneous human nuclear receptor subfamily 1 (PXR and 
constitutive androstane receptor (CAR), respectively), 
and are involved in overlapping pathways of xenobiotic 
detoxification, mainly occuring in the liver [62]. PXR is 
responsible for the expression of xenobiotic metabolising 
enzymes (e.g. cytochromes) in humans and is activated 
by a wide range of xenobiotics (e.g antibiotics) as well as 
endobiotics [63]. Activation of PXR has previously been 
observed by other azole fungicides such as miconazole 
and propiconazole [64] (see Fig. 7a, b). Moreoever, many 
conazoles are known to be involved in inhibition and 
induction of mammalian cytochromes P450 [65]. Gener-
ally, metabolism and elimination of foreign substances, 
such as fungicides, is favourable, it is mainly alarming 
when it comes to drug-drug interactions [66] (e.g. induc-
tion of xenobiotic metabolism by one drug may also 
affects metabolism and thus plasma levels of another 
drug). An example is the antimycotic drug ketoconazole 
(Fig. 7c) which is preferably applied topically rather than 
orally due to its high drug-drug interaction potential [67].
Triazoles1&2 were both predicted to have antagonistic 
effects on the thyroid receptor. Indeed, thyroid endocrine 
effects of triazole fungizides have not yet extensively been 
Fig. 7 Chemical structures of triazole and imidazole fungicides referred to in the case study section
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studied: There is no indication of an effect in mammali-
ans in vivo and only few reports in vitro and in zebrafish: 
Thyroid endocrine effects have previously been reported 
for two triazole fungicides hexaconazole and tebucona-
zole (see Fig. 7d, e) in zebrafish larvae [68]. Yu et al. sug-
gested that the latter two triazoles can influence both, 
thyroid hormone levels and gene transcription in the 
hypothalamic-pituitary-thyroid axis. Changing thyroid 
hormone levels can affect several important physiological 
processes, e.g. tissue growth and differentiation, energy 
homeostasis, and metabolism [69, 70].
Furthermore, triazoles1&2 were predicted to inter-
fere with the cell cycle, i.e. leading to cytotoxicity. Also, 
in literature, evidence for cytotoxicity and cell cycle 
inhibition by triazole fungicides or mixtures contain-
ing such is given. For instance, Schwarzbacherova et  al. 
reported cytotoxic and genotoxic effects, such as reduced 
cell viability, decreased cell proliferation, and apopto-
sis of bovine lymphocytes induced by fungicides [71]. 
In another study, they found bovine lymphocytes prolif-
eration inhibited by a mixture of two conazole fungicides 
[72]. Additionally, Zhou et  al. [73] described apoptotic 
effects of tebuconazole (see Fig. 7e) on human placental 
trophoblast cells.
Summarising, it could be shown that the CP models 
make reasonable predictions for potential toxic effects of 
these compounds, which could be substantiated with evi-
dence in literature.
Secondly, with a search for structural alerts, toxicity 
prediction is supported with information from literature 
about substructures that have been previously assigned 
to specific toxic endpoints. Each query compound is 
screened against totally 919 available alerts and any criti-
cal substructure is highlighted.
Three alerts found for triazoles1&2 are shown in 
Fig. 6c. According to Benigni et al. halogenated benzenes 
are prone to non-genotoxic carcinogenicity via agonis-
tic or antagonistic interaction with the aryl hydrocarbon 
receptor  (AhR) [74]. AhR activation can result in altered 
gene expression and thus various types of toxicity, e.g. 
immunotoxicity, liver tumor promotion, and carcino-
genicity [74, 75].
The sulfur moiety points to a study by Liu et  al. [40], 
where 23 drugs containing acyclic bivalent sulfur moie-
ties were investigated. Eight out of them are known for 
liver toxicity, another 14 are possibly hepatotoxic. Since 
only for one of the investigated drugs, liver toxicity could 
be excluded certainly, potential liver toxicity should be 
considered for these moieties. Conversely, this alert must 
not be an exclusion criterion, as the above drugs were 
still launched to the market.
Another warning is issued towards the epoxide sub-
structure, a highly reactive group. Presence of the oxygen 
makes the carbons in the three-membered ring electro-
philic. Thus they are typically accessed by nucleophiles, 
via an SN2-type mechanism resulting in ring opening 
and a covalent bond. This may cause mutagenic or carci-
nogenic effects, as well as skin sensitization and aquatic 
toxicity [39, 76–78]. While the nucleophile preferentially 
attacks the less substituted ring carbon, [76] in the case of 
triazoles1&2, access to any ring carbon is sterically hin-
dered due to the three surrounding substituents. Thus, 
the present epoxides can be considered inert.
Note that the issued warnings are based on the 919 
toxic alerts incorporated into KnowTox. If the collec-
tion of structural alerts is desired to be even more com-
prehensive, it can always be extended by literature or 
in-house knowledge. For example, the triazole substruc-
ture, which is also included in the ToxAlerts tool as an 
“extended functional group” [19, 79], is not considered in 
this work. As seen in the CP part, this moiety is respon-
sible for both, the antifungal activity, and adverse effects 
due to aromatase inhibition.
Thirdly, risk assessment is complemented through inclu-
sion of information from experimental ToxCast assay out-
comes of similar molecules. For a query compound, the 
7912 compounds of the ToxCast dataset are screened to 
identify the molecules with highest Tanimoto similarity 
and toxicity information of these most similar molecules is 
displayed. To simplify the assessment of the grade of simi-
larity, and thus the reliability in the read-across, the Tani-
moto index, as well as the MCS between the molecules are 
indicated. Similarity search and support for read-across 
can especially be valuable for those endpoints where 
minority class data was too few to build a CP model.
When querying the triazoles in the similarity search, 
eight fairly similar molecules are returned (see Fig.  6d). 
The similarity is mainly reflected in the triazole sub-
structure and halogenated benzenes, mostly connected 
in three- or four-membered ring-systems. Note that no 
other molecule with an epoxide substructure is captured 
within the similarity search.
Assuming that the found molecules are similar enough, 
known experimental information about them could be 
used to support read-across. Although ToxCast provides 
data from 985 assays, the most similar molecules to the 
two triazoles were only assayed for 32 to 639 endpoints 
each. The most similar molecule to triazole1, propicona-
zole, was, amongst others, tested active at several nuclear 
receptor-related endpoints (e.g. PXRe, CAR, androgen, 
thyroid and estrogen receptors), cytochromes P450 (i.e. 
19, 1a, 2b, 2c, 2d, 3a), and GPCRs (e.g. opioid receptors, 
muscarinic cholinergic receptors, and histamine receptor 
H2). Furthermore, it had effects on several developmental 
endpoints of zebrafish embryos [80] (see Fig. 6e). Experi-
mentally observed activity for bromuconazole, the most 
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similar compound to triazole2, was mainly restricted to 
nuclear receptors (e.g. retinoic acid, androgen, and estro-
gen receptors, PXR), DNA binding (AhR, p53, sterol reg-
ulatory element binding protein), and cytochromes P450 
(19A1, 2a, 2b, 2c, 3a). It should, moreover, be noted that 
Br-substituents, as in bromuconazole, are generally more 
reactive than F- or Cl-substituents [39]. So, certain toxic 
effects might be more distinct in bromuconazole than 
in molecules without Br- substituted moieties, such as 
triazoles1&2.
The toxic effects described for triazoles1&2 above can 
be related to pathways, such as CAR/RXR and PXR/RXR 
activation, xenobiotic metabolism signaling, and AhR 
signaling, which were also investigated in a study by Hes-
ter et al. [65] and related to hepatocarcinogenesis.
An association of bromuconazole with xenobiotic 
metabolism and nuclear receptors (i.e. PXR), as sug-
gested by the similarity-based read-across, is further sup-
ported by a recent study by Abdelhadya et al. [81]. They 
reported, inter alia, that the liver oxidative damage is 
associated with increased PXR activity and concurrent 
decrease in expression of the CAR gene.
In conclusion, indications of liver toxicity, liver enzyme 
induction, and aromatase inhibition were found in rats 
treated with these two triazoles in in-house studies. Thus, 
further development of these two triazole candidates 
was discontinued. Also, according to literature, several 
conazole fungicides have been associated to potential AA 
endocrine disruption [82]. For example, AA effects were 
reported for prochloraz (Fig. 7f ) in human prostate can-
cer cells [83]. Also, propiconazole (Fig.  7b) showed AA 
activity in vitro, though it could not be asserted in vivo 
[84]. Moreover, another explanation for triazole-induced 
liver toxicity was recently provided by Knebel et al. who 
investigated molecular mechanisms of hepatic steatosis 
[85]. The triazole fungicides propiconazole and tebucon-
azole (see Fig. 7b, e) were shown to influence the expres-
sion of steatosis-related genes. Especially, the observed 
additivity of equimolar mixtures suggests a common 
mode of action.
To conclude, KnowTox was able to predict many inter-
actions, especially with respect to the induction of xeno-
biotic enzymes, endocrine effects, and liver toxicity. The 
discussed predictions could be supported by literature 
findings for other related molecules. Also, the KnowTox 
tool could reproduce the main in vivo effects of two tria‑
zole compounds, which have been discontinued as devel-
opment candidates.
To sum up, such a holistic analysis of the toxic potential 
of a novel molecule can be of high reward in compound 
(de-)selection, planning further toxicity testing, and to 
support read-across. Nevertheless, its benefit can still be 
increased by incorporation of larger datasets, biological 
activity fingerprints characterising the compounds, and 
in vivo endpoint data for model development. Note that 
KnowTox is based on the ToxCast dataset chosen for its 
size, scope and accessibility. Used in early stages of new 
chemical’s development, the tool can provide a broad 
overview on possible interactions with toxicity-related 
targets. For application in regulatory toxicity testing, it 
is beneficial to have toxicity data which fundamentally 
support regulatory required toxicity assays in animals, 
e.g. reproduction toxicity studies. In case of occurrence 
of toxic effects, the tool will help to identify a potential 
mode-of-action. In addition, it will increase certainty 
if data support the absence of toxic effects. Thus, if, in 
future, sufficient standard toxicity data will be avail-
able for model training, the introduced pipeline has the 
potential to become even more powerful. Also, informa-
tion about the compound’s bioavailability and in vitro to 
in vivo translation of the assays would be of high interest 
[10, 86–88]. According to Grenet et al. [87], it seems to be 
more challenging to predict long-term in vivo endocrine 
disruption, compared to predicting short-term in  vivo 
endocrine effects. Furthermore, for a complete risk 
assessment, the quantitative dose-response needs to be 
considered. That is beyond the scope of this paper. Infor-
mation on the type and amount of formed metabolites 
is highly desirable (see the prominent role of xenobiotic 
metabolism in the toxic effects of triazole fungicides).
In vitro toxicology has embarked on combining data 
from different sources to derive more reliable and more 
relevant information on potential toxic effects of com-
pounds [89, 90]. This concept also applies to in silico tox-
icology and combinations of the different in vivo, in vitro, 
in silico methods: combining the input from different, 
complementary models can provide advantageous infor-
mation which cannot be obtained from one single source.
Conclusion
In silico methods for toxicity prediction are promising 
tools assisting in the reduction and replacement of ani-
mal testing. In this work, three different approaches were 
combined in order to support holistic risk assessment for 
new query molecules.
In praxis, it is not only important to have well per-
forming models, but also to know that they can be 
confidently applied to novel compounds (applicability 
domain), that the predictions are reliable (reliability 
domain) and informative (decidability domain). A pop-
ular technique for confidence estimation for machine 
learning models is conformal prediction, which enables 
straightforward training of valid and balanced models 
with little optimisation effort. While this advantage was 
also witnessed during internal validation, in this work, 
some challenges emerged during application to an 
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external dataset where exchangeability was not given. 
Therefore, the models were refined in two steps: firstly, 
using k-nearest neighbour normalisation improved 
validity of both internal and in-house data predictions 
(reliability domain). Secondly, random equal size sam-
pling of the training set improved informational effi-
ciency of the predictions (decidability domain). This 
strategy was initially validated on an AA model and 
subsequently transferred to totally 88 ToxCast end-
point models. Complemented with structural alerts 
from literature and providing support for read-across, 
the KnowTox tool generates a risk assessment picture 
to examine potential toxicity of a novel query com-
pound from different angles as exemplified by the case 
study on two triazoles.
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